De Bie, F. R., Halline, C., Kotzur, T., Hayes, K., Chang, J., Larson, A., … Partridge, E. (2022). Prenatal treprostinil improves the pulmonary hypertensive phenotype in the nitrofen model of congenital diaphragmatic hernia. In AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (Vol. 226, pp. S50–S51).

De Bie, Felix R., Christopher Halline, Travis Kotzur, Kevin Hayes, Jonathan Chang, Abby Larson, Sameer Khan, et al. “Prenatal treprostinil improves the pulmonary hypertensive phenotype in the nitrofen model of congenital diaphragmatic hernia.” In AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 226:S50–51, 2022.

De Bie FR, Halline C, Kotzur T, Hayes K, Chang J, Larson A, et al. Prenatal treprostinil improves the pulmonary hypertensive phenotype in the nitrofen model of congenital diaphragmatic hernia. In: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2022. p. S50–1.

De Bie, Felix R., et al. “Prenatal treprostinil improves the pulmonary hypertensive phenotype in the nitrofen model of congenital diaphragmatic hernia.” AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol. 226, no. 1, 2022, pp. S50–51.

De Bie FR, Halline C, Kotzur T, Hayes K, Chang J, Larson A, Khan S, Didier RA, Sridharan A, Russo F, Deprest J, Hedrick H, Partridge E. Prenatal treprostinil improves the pulmonary hypertensive phenotype in the nitrofen model of congenital diaphragmatic hernia. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2022. p. S50–S51.